Recursion Pharmaceuticals
About Recursion Pharmaceuticals
Recursion Pharmaceuticals is a clinical-stage TechBio company that decodes biology and chemistry to industrialize drug discovery. Leveraging its Recursion Operating System (OS), the company uses a platform built across diverse technologies to map and navigate biological and chemical relationships, accelerating the discovery of treatments for various diseases. They combine experimental biology, bioinformatics, and artificial intelligence in a hybrid lab-to-cloud platform.
Company Details
- Website
- https://www.recursion.com
- Funding
- IPO
- Total Raised
- $509.79M
- Stock Ticker
- RXRX
- https://www.linkedin.com/company/recursion-pharmaceuticals/
Specializations
- TechBio
- AI/ML
- Drug Discovery
- Biotechnology
- Rare Diseases
Products & Solutions (1)
| Product | Category | Sub-Category | Description |
|---|---|---|---|
| Recursion OS | research-development | Drug Discovery AI | Phenomics-based drug discovery and development |
Notable Customers
- Bayer AG
- Roche
- Genentech
- Takeda Pharmaceutical Company Limited
- NVIDIA
- Google Cloud